• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    Amgen Inc. (AMGN)

    -NasdaqGS
    160.55 Mar 26, 4:00PM EDT
    |Pre-Market : 161.42 Up 0.85 (0.53%) 9:06AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:160.55
    Open:N/A
    Bid:161.00 x 100
    Ask:162.25 x 300
    1y Target Est:176.42
    Beta:0.58
    Next Earnings Date:21-Apr-15AMGN Earnings announcement
    Day's Range:N/A - N/A
    52wk Range:108.20 - 173.14
    Volume:240
    Avg Vol (3m):3,508,970
    Market Cap:121.84B
    P/E (ttm):23.96
    EPS (ttm):6.70
    Div & Yield:3.16 (1.90%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    AMGN 0.00%121.84B
    JNJ278.44B
    NVS238.81B
    TEVA53.17B

    Key Statistics

    Forward P/E (1 yr):15.29
    P/S (ttm):6.07
    Ex-Dividend Date:12-May-15

    Analysts

    Annual EPS Est (Dec-15) :9.31
    Quarterly EPS Est (Mar-15) :2.11
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):1.55

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback